Noninvasive testing is highlighted as a vital tool for risk stratification and monitoring of NAFLD patients, offering a safer alternative to biopsies. The Clinical Practice Update Expert Review by the American Gastroenterological Association emphasizes the importance of noninvasive testing in enhancing patient care by detecting advanced fibrosis early. The update provides best practice advice for the optimal use of noninvasive tests in NAFLD patients, aiming to improve outcomes and facilitate timely clinical management. Key points include the recommendation to use various noninvasive tests for risk stratification, the importance of interpreting results in the context of clinical data, and the need for longitudinal monitoring to guide treatment decisions.
Başka Bir Dile
kaynak içeriğinden
www.medscape.com
Önemli Bilgiler Şuradan Elde Edildi
by Will Pass : www.medscape.com 09-20-2023
http://www.medscape.com/viewarticle/996634Daha Derin Sorular